HLA-B59(155286-92-3)
- Name: HLA-B59
- Synonyms:AntigenHLA-B 59 (human precursor reduced)
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:155286-92-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.155286-92-3 HLA-B59
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 75848-22-5/Kuaishaling
- 14617-67-5/4-(acetylamino)-4,5-dihydro-1,2-oxazol-3-yl 4-methylbenzenesulfonate
- 185463-98-3/Buthinin (reduced)
- 125360-38-5/MalI protein
- 42469-56-7/2-[3-(trifluoromethyl)phenyl]-1,3-oxazole-4,5-dicarboxamide
- 55840-91-0/Benzamide,3,5-dimethyl-N-(1-methylethyl)- N-(phenylmethyl)-,mixt. with 2,2-dimethyl-N-(1-methylethyl)-N-(phenylmethyl) propanamide
- 84339-08-2/5H-Thiazolo(3,2-a)quinoline-4-carboxylic acid, 7-fluoro-1-methyl-5-oxo -8-(1-piperazinyl)-, hydrate (2:1)
- 20914-56-1/9-amino-3,9-dihydro-6H-purine-6-thione
- 94551-93-6/Slimes and Sludges, steel rolling
- 4889-40-1/5-oxoproline, compound with piperazine (1:1)
- 1912-47-6/5-METHYLINDOLE-3-ACETIC ACID
- 22820-30-0/1-(2,4-dichlorophenoxy)-3-{[2-(morpholin-4-yl)ethyl](propan-2-yl)amino}propan-2-ol dihydrochloride
- 136958-07-1/Brain P75 binding protein
- 67762-86-1/POLY(CYANOPROPYLMETHYLSILOXANE)
- 18595-14-7/Methyl 4-amino-3-methylbenzoate
- 67370-02-9/Angeloylzygadenine
- 145459-19-4/Heterophyllin B
- 171964-49-1/1H-Cyclobut[e]indene-1,2,4-triol,2,4,4a,5,6,7,- 7a,7b-octahydro-3-(hydroxymethyl)-6,6,7btrimethyl-,(1S,2R,4S,4aR,7aS,7bR)-
- 54425-42-2/St2A
- 155286-92-3/HLA-B59
- 145274-77-7/b-D-Glucopyranose, cyclic 2®2:3®2'-[(1S)-4-(6-carboxy-2,3,4-trihydroxyphenoxy)-4',5,5',6,6'-pentahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]cyclic 4,6-O-[(1S)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]1-(3,4,5-trihydroxybenzoate), 4-ester with b-D-glucopyranose cyclic 2®2:3®2'-[(1S)-4,5,5',6,6'-pentahydroxy-4'-[2,3,4-trihydroxy-6-(methoxycarbonyl)phenoxy][1,1'-biphenyl]-2,2'-dicarboxylate]1,6-bis(3,4,5-trihydroxybenzoate) (9CI)
- 28567-35-3/tert-butyl diphenylmethyl ether
- 166582-81-6/Benzaldehyde,2,4-dihydroxy-6-methyl-3-[(2E,4R)-3-methyl-4-(1-oxopropoxy)-5-[(1S,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]-2-penten-1-yl]-
- 65273-61-2/[2-(1,3-dihydro-2H-isoindol-2-yl)ethyl](triphenyl)phosphonium
- 108444-25-3/1-BENZYL-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
- 78518-19-1/Spiro[cyclopropa[1,10a]phenanthro[4,5-bcd]- furan-3(1H),2'-oxirane]-9b(3aH)-ethanamine,1a,2-dihydro-5-methoxy-N,N-dimethyl-,(1aS,2'S,3aR,9aS,9bS)-
- 5528-56-3/5,7-dimethyl-3-phenyl[1,2,4]triazolo[4,3-a]pyridine
- 4482-53-5/Phosphine,tris(3-arsinopropyl)-
- 87081-19-4/4-(1-hydroxy-2-{[(2-methyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amino}propyl)phenol hydrobromide
- 72117-56-7/2-[[[(4-bromophenyl)sulfonylamino]carbamoylformyl]amino]benzoic acid